Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma

por Xu, Jian‐ping, Hao, Xue‐zhi, Zhang, Xiang‐ru, Yang, Sheng, Shi, Yuan‐kai
Publicado 2015

A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations

por Li, Hong‐Shuai, Zhang, Jin‐Yao, Yan, Xiang, Xu, Hai‐Yan, Hao, Xue‐Zhi, Xing, Pu‐Yuan, Wang, Yan
Publicado 2022

Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC and brain metastases

por Zhang, Jinyao, Wang, Yan, Liu, Ziling, Wang, Lin, Yao, Yu, Liu, Yutao, Hao, Xue Zhi, Wang, Jianyang, Xing, Puyuan, Li, Junling
Publicado 2021

Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review

por Li, Hong-Shuai, Lei, Si-Yu, Li, Jun-Ling, Xing, Pu-Yuan, Hao, Xue-Zhi, Xu, Fei, Xu, Hai-Yan, Wang, Yan
Publicado 2022

Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR ‐mutant non‐small cell lung cancer

por Lei, Si‐Yu, Xu, Hai‐Yan, Li, Hong‐Shuai, Yang, Ya‐Ning, Xu, Fei, Li, Jun‐Ling, Wang, Zhi‐Jie, Xing, Pu‐Yuan, Hao, Xue‐Zhi, Wang, Yan
Publicado 2023

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

por Liu, Yu-Tao, Hao, Xue-Zhi, Li, Jun-Ling, Hu, Xing-Sheng, Wang, Yan, Wang, Zi-Ping, Wang, Hong-Yu, Wang, Bin, Han, Xiao-Hong, Zhang, Xiang-Ru, Shi, Yuan-Kai
Publicado 2015

The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy

por Zhang, Ning-Ning, Liu, Yu-Tao, Ma, Li, Wang, Lin, Hao, Xue-Zhi, Yuan, Zheng, Lin, Dong-Mei, Li, Dan, Zhou, Yu-Jie, Lin, Hua, Han, Xiao-Hong, Sun, Yan, Shi, Yuankai
Publicado 2014

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

por Liu, Yu-Tao, Zhang, Kai, Li, Cheng-Cheng, Hu, Xing-Sheng, Jiang, Jun, Hao, Xue-Zhi, Wang, Yan, Li, Jun-Ling, Xing, Pu-Yuan, Yang, Sheng, Zhang, Xin, Wang, Guo-Qiang, Cai, Shang-Li, Shi, Yuan-Kai
Publicado 2019

Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparati...

por Li, Hong-Shuai, Wang, Shou-Zheng, Xu, Hai-Yan, Yan, Xiang, Zhang, Jin-Yao, Lei, Si-Yu, Li, Teng, Hao, Xue-Zhi, Zhang, Tao, Yang, Guang-Jian, Zhou, Li-Qiang, Liu, Peng, Wang, Yu-Ying, Hu, Xing-Sheng, Xing, Pu-Yuan, Wang, Yan
Publicado 2022

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial

por Liu, Yu-Tao, Hao, Xue-Zhi, Liu, De-Ruo, Cheng, Gang, Zhang, Shu-Cai, Xiao, Wen-Hua, Hu, Yi, Liu, Jun-Feng, He, Ming, Ding, Cui-Min, Zhang, Li, Wang, Jun, Li, Hui, Dong, Gui-Lan, Zhi, Xiu-Yi, Li, Jian, Shi, Yuan-Kai
Publicado 2020

Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients

por Huang, Li‐Ling, Hu, Xing‐Sheng, Wang, Yan, Li, Jun‐Ling, Wang, Hong‐Yu, Liu, Peng, Xu, Jian‐Ping, He, Xiao‐Hui, Hao, Xue‐Zhi, Jiang, Pei‐Di, Liu, Yu‐Tao, Luo, Jian, Zhou, Sheng‐Yu, Wang, Jin‐Wan, Yang, Jian‐Liang, Qin, Yan, Yuan, Peng, Lin, Lin, Shi, Yuan‐Kai
Publicado 2021